Long-term excess mortality of 244 familial and 1502 sporadic one-year survivors of aneurysmal subarachnoid hemorrhage compared with a matched eastern finnish catchment population

Neurosurgery

Volumn 68, Issue 1, 2011, Pages 20-27

  Huttunen, Terhi ^a   Von Und Zu Fraunberg, Mikael ^a   Koivisto, Timo ^a   Ronkainen, Antti ^a   Rinne, Jaakko ^a   Sankila, Risto ^b   Seppä, Karri ^b   Jääskeläinen, Juha E ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

Causes of death; Familial; Long term excess mortality; Saccular intracranial aneurysm; Sporadic; Subarachnoid hemorrhage

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASILAR ARTERY; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; CAUSE OF DEATH; CHILD; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; FINLAND; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; HYDROCEPHALUS; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RESIDENTIAL CARE; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; SURVIVOR;

AGED; FEMALE; FINLAND; GLASGOW OUTCOME SCALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SUBARACHNOID HEMORRHAGE; SURVIVORS;

EID: 78650875212     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181ff33ca     Document Type: Article

References (46)

1. Ronkainen A, Miettinen H, Karkola K, et al. Risk of harboring an unruptured intracranial aneurysm. Stroke. 1998;29(2):359-362.
2. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306-318.
3. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40(3):994-1025.
4. Levine JM. Critical care management of subarachnoid hemorrhage. Curr Treat Options Neurol. 2009;11(2):126-136.
5. Guresir E, Beck J, Vatter H, et al. Subarachnoid hemorrhage and intracerebral hematoma: incidence, prognostic factors, and outcome. Neurosurgery. 2008;63(6):1088-1093; discussion 1093-1094.
6. Hernesniemi J, Vapalahti M, Niskanen M, et al. One-year outcome in early aneurysm surgery: a 14 years experience. Acta Neurochir (Wien). 1993;122(1-2):1-10.
7. Langham J, Reeves BC, Lindsay KW, et al. Variation in outcome after subarachnoid hemorrhage: a study of neurosurgical units in UK and Ireland. Stroke. 2009;40(1):111-118.
8. Lehecka M, Lehto H, Niemela M, et al. Distal anterior cerebral artery aneurysms: treatment and outcome analysis of 501 patients. Neurosurgery. 2008;62(3):590- 601; discussion 590-601.
9. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488):809-817.
10. O'Kelly CJ, Kulkarni AV, Austin PC, Urbach D, Wallace MC. Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: incidence, predictors, and revision rates. Clinical article. J Neurosurg. 2009;111(5):1029-1035.
11. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007; 38(8):2315-2321.
12. van der Bilt IA, Hasan D, Vandertop WP, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology. 2009;72(7):635-642.
13. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34(3):617-23; quiz 624.
14. Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med. 2009;360(17):1759-1768.
15. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA. 2009;106(23):9362-9367.
16. Ronkainen A, Niskanen M, Rinne J, Koivisto T, Hernesniemi J, Vapalahti M. Evidence for excess long-term mortality after treated subarachnoid hemorrhage. Stroke. 2001;32(12):2850-2853.
17. Lehecka M, Niemela M, Seppanen J, et al. No long-term excess mortality in 280 patients with ruptured distal anterior cerebral artery aneurysms. Neurosurgery. 2007;60(2):235-240; discussion 240-241.
18. Molyneux AJ, Kerr RS, Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009;8(5):427-433.
19. Olafsson E, Hauser WA, Gudmundsson G. A population-based study of prognosis of ruptured cerebral aneurysm: mortality and recurrence of subarachnoid hemorrhage. Neurology. 1997;48(5):1191-1195.
20. Wermer MJ, Greebe P, Algra A, Rinkel GJ. Long-term mortality and vascular event risk after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2009;80(12):1399-1401.
21. Bilguvar K, Yasuno K, Niemela M, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet. 2008;40(12):1472-1477.
22. Frosen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004;35(10):2287-2293.
23. Frosen J, Piippo A, Paetau A, et al. Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery. 2006;58(3):534-541; discussion 534-541.
24. Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40(2):217-224.
25. Laaksamo E, Tulamo R, Baumann M, et al. Involvement of mitogen-activated protein kinase signaling in growth and rupture of human intracranial aneurysms. Stroke. 2008;39(3):886-892.
26. Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet. 1997;349(904):380-384.
27. Ronkainen A, Niskanen M, Piironen R, Hernesniemi J. Familial subarachnoid hemorrhage. Outcome study. Stroke. 1999;30(5):1099-1102.
28. Tulamo R, Frosen J, Junnikkala S, et al. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery. 2006;59(5):1069-1076; discussion 1076-1077.
29. van der Voet M, Olson JM, Kuivaniemi H, et al. Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet. 2004;74(3):564-571.
30. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78(12):1365-1372.
31. Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet. 1999;8(10):1913-1923.
32. Huttunen T, von und zu Fraunberg M., Frösen J, et al. Saccular intracranial aneurysm disease: distribution of site, size, and age suggests different etiologies for aneurysm formation and rupture in 316 familial and 1454 sporadic eastern Finnish patients. Neurosurgery. 2010;66(4):631-638; discussion 638.
33. Fogelholm R, Hernesniemi J, Vapalahti M. Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke. 1993;24(11):1649-1654.
34. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101-121.
35. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958;8(6):699-712.
36. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;38(4):933-942.
37. Estève J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med. 1990;9(5):529-538.
38. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51-64.
39. Stare J, Pohar M, Henderson R. Goodness of fit of relative survival models. Stat Med. 2005;24(24):3911-3925.
40. Pohar M, Stare J. Relative survival analysis in R. Comput Methods Programs Biomed. 2006;81(3):272-278.
41. R Development Core Team. R. A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. 2009. Available at: http:// www.R-project org. Accessed November 4, 2010.
42. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992;31(1):2-12.
43. Laakso A, Dashti R, Seppanen J, et al. Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery. 2008;63(2):244-253; discussion 253-255.
44. Lahermo P, Sajantila A, Sistonen P, et al. The genetic relationship between the Finns and the Finnish Saami (Lapps): analysis of nuclear DNA and mtDNA. Am J Hum Genet. 1996;58(6):1309-1322.
45. Salmela E, Lappalainen T, Fransson I, et al. Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS ONE. 2008;3(10):e3519.
46. Lappalainen T, Koivumaki S, Salmela E, et al. Regional differences among the Finns: a Y-chromosomal perspective. Gene. 2006;376(2):207-215.